SIMILASAN Maux de voyage glob fl 15 g
7680678120014
CH-67812
20.01.1.
1 / 3
google
Details
- Product number
- 6781201
- CPT
- -
- Packaging group
- 15.0
- Unit
- g
- Composition
- nux-vomica (Ph.Eur.Hom.) D15 (Ph.Eur.Hom. 1.1.8) 2.500 mg, hyoscyamus niger (HAB) D15 2.500 mg, petroleum rectificatum (HAB) D15 2.500 mg, anamirta cocculus (HAB) D15 (Ph.Eur.Hom. 1.1.8) 2.500 mg, calcii carbonas, xylitolum 600.00 mg, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.
Articles (1)
Similasan Reisekrankheit, Globuli
Globuli
15.0
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
600.0 MG | Substance | HNIDK |
Authorization holder
Similasan AG
8916 Jonen
Authorization information
- Swissmedic authorization number
- 67812
- Drug name
- Similasan Reisekrankheit, Globuli
- Galenic form
- GLO
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 16/12/2021
- Authorization expiration date
- 15/12/2026
- IT number
- 20.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SIMILASAN Maux de voyage glob fl 15 g
- Description (DE)
- SIMILASAN Reisekrankheit Glob Fl 15 g
- Market launch
- 16/12/2021
- Narcotic (BTM)
- No